Abstract

This study establishes a new approach for combining neuroimaging and neuropsychological measures for an optimal decisional space to classify subjects with Alzheimer's disease (AD). This approach relies on a multivariate feature selection method with different MRI normalization techniques. Subcortical volume, cortical thickness, and surface area measures are obtained using MRIs from 189 participants (129 normal controls and 60 AD patients). Statistically significant variables were selected for each combination model to construct a multidimensional space for classification. Different normalization approaches were explored to gauge the effect on classification performance using a support vector machine classifier. Results indicate that the Mini-mental state examination (MMSE) measure is most discriminative among single-measure models, while subcortical volume combined with MMSE is the most effective multivariate model for AD classification. The study demonstrates that subcortical volumes need not be normalized, whereas cortical thickness should be normalized either by intracranial volume or mean thickness, and surface area is a weak indicator of AD with and without normalization. On the significant brain regions, a nearly perfect symmetry is observed for subcortical volumes and cortical thickness, and a significant reduction in thickness is particularly seen in the temporal lobe, which is associated with brain deficits characterizing AD.

Highlights

  • Alzheimer’s disease (AD) is a neurodegenerative disease and is the most common form of dementia

  • This paper studied the effect of normalization on the proposed statistical feature selection approach using regions of interest (ROI) segmented by Freesurfer and a neuropsychological test in terms of classification performance

  • The results shows that subcortical volume should not be normalized and surface area does not bear much discriminative information as compared to subcortical volumes or cortical thickens

Read more

Summary

Introduction

Alzheimer’s disease (AD) is a neurodegenerative disease and is the most common form of dementia. Estimates from the Alzheimer Association as of March 2012 indicate that 5.4 million Americans are diagnosed with AD, and over 95% of this population are 65 years of age or older. Nearly half of the population over 85 years of age is affected by AD [1]. The worldwide societal cost of dementia is enormous, which is estimated to be 315.4 billion USD on the basis of a 29.3 million population diagnosed with dementia [2]. AD patients display disease-related regional cerebral atrophy, which can be distinguished from normal aging [3, 4]. Determination of the key atrophied regions across the entire brain could be used as parameters for the delineation of AD patients from cognitively normal (CN) subjects

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call